Literature DB >> 10072627

Urolithiasis and the protease inhibitor indinavir.

J Hermieu1, M Prévot, V Ravery, L Sauty, F Moulinier, V Delmas, E Bouvet, L Boccon-Gibod.   

Abstract

OBJECTIVE: To evaluate specific urological abnormalities in patients treated with the protease inhibitor indinavir.
METHODS: A series of 155 consecutive human immunodeficiency virus-positive patients were treated with indinavir 800 mg p.o. three times a day. Of these, 14 (9%) treated for 1-321 (average 110) days experienced severe flank pain and were subjected to clinical and laboratory examinations.
RESULTS: Abdominal X-ray was consistently negative for stones. Ultrasonography showed upper-tract dilatation in 12 patients. Intravenous urography showed obstruction above a radiolucent obstacle in 7 patients; in 2 cases, there was a marked delay in urine excretion on the obstructed side. The mean urine pH was 6. Urine culture was negative. Serum uric acid, phosphorus, and calcium levels were normal. In 8 patients there was slight renal insufficiency, and 4 patients required ureteral stenting. In all cases, hyperhydration and oral analgesia led to a favorable outcome. In 3 patients, chemical analysis of the stone demonstrated monohydrate indinavir crystals.
CONCLUSIONS: In our experience, indinavir therapy is associated with urolithiasis in 9% of the cases. Hydration, analgesia, and acidification of the urine usually lead to a favorable clinical outcome. Prophylactic hydration and acidification of the urine are extremely important.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10072627     DOI: 10.1159/000019854

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  5 in total

Review 1.  [Imaging techniques and their impact in treatment management of patients with acute flank pain].

Authors:  A Grosse; C A Grosse; J Mauermann; G Heinz-Peer
Journal:  Radiologe       Date:  2005-10       Impact factor: 0.635

Review 2.  Drug-Induced Kidney Stones and Crystalline Nephropathy: Pathophysiology, Prevention and Treatment.

Authors:  Michel Daudon; Vincent Frochot; Dominique Bazin; Paul Jungers
Journal:  Drugs       Date:  2018-02       Impact factor: 9.546

3.  Hypercalciuria is the main renal abnormality finding in Human Immunodeficiency Virus-infected children in Venezuela.

Authors:  Corina Gonzalez; G Ariceta; C B Langman; P Zibaoui; L Escalona; L F Dominguez; M A Rosas
Journal:  Eur J Pediatr       Date:  2007-06-26       Impact factor: 3.183

Review 4.  Drug-induced renal calculi: epidemiology, prevention and management.

Authors:  Michel Daudon; Paul Jungers
Journal:  Drugs       Date:  2004       Impact factor: 9.546

Review 5.  Renal effects of non-tenofovir antiretroviral therapy in patients living with HIV.

Authors:  Milena M McLaughlin; Aimee J Guerrero; Andrew Merker
Journal:  Drugs Context       Date:  2018-03-21
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.